Antibiotic prescribing practice in the spinal cord injury system of care
Antibiotic prescribing practice in the spinal cord injury system of care
批准号:
8846420
负责人:
CHARLESNIKA T EVANS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-01-01 至 2015-12-31
关键词:
AddressAdmission activityAntibiotic ResistanceAntibiotic TherapyAntibiotic-resistant organismAntibioticsAntimicrobial ResistanceAreaCaringCathetersCharacteristicsChronicDataDecision MakingDecubitus ulcerDevelopmentDiseaseEffectivenessEnsureEvaluationEvidence based practiceGeneral PopulationGoalsGram-Negative BacteriaHealth PersonnelHealthcareHospitalizationHospitalsIn VitroIndividualInfectionInterventionLong-Term CareMedicalMedical DeviceMedical centerMethodsMicrobiologyMorbidity - disease rateMulti-Drug ResistanceOrganismOutcomeOutcome StudyPatientsPersonsPopulationPopulation StudyPrevalencePrimary Health CareProcessProviderQuality of CareReportingResistanceResourcesRiskSepsisServicesSpinal cord injurySpinal cord injury patientsStrategic PlanningSummary ReportsSystemTestingUrinary tract infectionVariantVeteransWorkantimicrobialcare systemsclinical practicedisabilityeffective interventionhigh riskimprovedmedical specialtiesmethicillin resistant Staphylococcus aureusmicroorganismmortalitymultidisciplinarypatient populationpressurepreventprogramsurinary
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Individuals with spinal cord injury or disorder (SCI/D) are at high risk for infections compared
to the general patient population due to factors such as frequent hospitalization, previous
antibiotic use, frequent and chronic use of invasive medical devices such as urinary catheters,
and development of pressure ulcers. Many of these infections are caused by antimicrobial
resistant organisms such as multidrug-resistant gram-negative bacteria or Methicillin-resistant
Staphylococcus aureus. Because infections often require antimicrobial treatment, the
opportunities for over-prescribing of antibiotics or inadequate antibiotic prescribing are common.
The goal of antimicrobial stewardship programs are to optimize antibiotic use by limiting
overuse and improving inadequate treatment while minimizing unintended consequences such
as the selection of antibiotic resistant organisms. Antibiotic resistance increases the likelihood of
initial inadequate therapy. Inadequate antibiotic therapy refers to treatment that does not have
`in vitro' effectiveness against a particular microorganism; in other words, the microorganism is
not susceptible to the particular antibiotic prescribed. There is a well-documented need to
prevent inadequate antibiotic treatment of infections, due to its impact on patient outcomes,
through the implementation of antimicrobial stewardship resources and programs. Antibiograms
(summaries reporting resistance of all tested microbiology isolates from patients at a facility- or
unit-level) have been shown to be an effective intervention in improving empiric prescribing. In
persons with SCI/D, this is even more important due to their increased risk of infection.
However, very little work has focused on identifying modifiable patient, provider, and/or system
level characteristics associated with inadequate antibiotic therapy in treating these common
infections among individuals with SCI/D; nor in implementation of effective antimicrobial
stewardship interventions such as using antibiograms. VA services for Veterans with SCI/D are
delivered through a hub and spoke system of care, extending from 25 regional SCI/D Centers
offering primary care and specialty care by multidisciplinary teams (hubs) to the 134 SCI/D
Primary Care teams (spokes) at local VA medical centers. Understanding the impact of this hub
and spoke system in provider decision-making is needed to ensure effective antimicrobial
stewardship strategies that reduce the prevalence of inadequate prescribing as well as
decrease the negative impact of related outcomes, such as higher hospital admission and
mortality rates. This is important to assess considering that up to 50% of SCI patients may only
be seen in a VHA facility without a specialty SCI/D Center. The proposed study addresses the
SCI QUERI strategic plan priority area of improving treatment and management of infections in
Veterans with SCI/D and will focus on Steps 3-4 of the QUERI process. As part of an overall
goal of improving antimicrobial stewardship in this population, we propose to conduct a national
mixed-methods study to assess variation in inadequate prescribing in BSI by hub and spoke
facilities and implement a pilot antibiogram intervention to improve prescribing.¿
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
-
批准号:10672768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
-
批准号:10620614
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
-
批准号:10312278
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
-
批准号:10187395
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
HSR&D Research Career Scientist Award
-
批准号:10535424
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
HSR&D Research Career Scientist Award
-
批准号:10005574
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
-
批准号:10186505
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
-
批准号:9502631
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
-
批准号:9695865
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
-
批准号:9205309
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
-
批准号:10200821
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Burden and Outcomes of Resistant Gram-negative Organisms in Veterans with SCI/D
-
批准号:8818457
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Burden and Outcomes of Resistant Gram-negative Organisms in Veterans with SCI/D
-
批准号:9040024
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
C. Difficile Outcomes and Effectiveness of Treatment Strategies in SCI
-
批准号:8082154
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
C. Difficile Outcomes and Effectiveness of Treatment Strategies in SCI
-
批准号:8292933
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CHARLESNIKA T EVANS
-
依托单位: